Intellectus Partners’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Hold |
61,425
| – | – | 0.05% | 259 |
|
|
2025
Q1 | $161K | Hold |
61,425
| – | – | 0.04% | 256 |
|
|
2024
Q4 | $253K | Sell |
61,425
-6,250
| -9% | -$25.8K | 0.06% | 238 |
|
|
2024
Q3 | $479K | Hold |
67,675
| – | – | 0.12% | 187 |
|
|
2024
Q2 | $441K | Sell |
67,675
-1,585
| -2% | -$10.3K | 0.12% | 181 |
|
|
2024
Q1 | $575K | Buy |
69,260
+19,400
| +39% | +$161K | 0.15% | 174 |
|
|
2023
Q4 | $549K | Sell |
49,860
-700
| -1% | -$7.71K | 0.16% | 167 |
|
|
2023
Q3 | $425K | Buy |
50,560
+2,000
| +4% | +$16.8K | 0.13% | 187 |
|
|
2023
Q2 | $610K | Buy |
48,560
+21,675
| +81% | +$272K | 0.18% | 159 |
|
|
2023
Q1 | $443K | Sell |
26,885
-1,900
| -7% | -$31.3K | 0.14% | 180 |
|
|
2022
Q4 | $430K | Buy |
28,785
+2,800
| +11% | +$41.8K | 0.15% | 175 |
|
|
2022
Q3 | $581K | Buy |
25,985
+1,725
| +7% | +$38.6K | 0.21% | 133 |
|
|
2022
Q2 | $406K | Buy |
24,260
+1,790
| +8% | +$30K | 0.14% | 181 |
|
|
2022
Q1 | $673K | Sell |
22,470
-3,700
| -14% | -$111K | 0.2% | 130 |
|
|
2021
Q4 | $804K | Sell |
26,170
-8,024
| -23% | -$247K | 0.2% | 131 |
|
|
2021
Q3 | $1.08M | Buy |
34,194
+150
| +0.4% | +$4.73K | 0.26% | 104 |
|
|
2021
Q2 | $1.25M | Buy |
34,044
+9,189
| +37% | +$336K | 0.28% | 93 |
|
|
2021
Q1 | $859K | Buy |
24,855
+15,105
| +155% | +$522K | 0.24% | 129 |
|
|
2020
Q4 | $405K | Buy |
+9,750
| New | +$405K | 0.12% | 175 |
|